Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy P Ho

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cell Research|June 3, 2008
The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in diseasePeggy P Ho, Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitisPeggy P Ho, Lawrence Steinman
Neurology(R) Neuroimmunology & Neuroinflammation|March 9, 2017
Time correlation between mononucleosis and initial symptoms of MSJohn Endriz, Peggy P Ho, Lawrence Steinman
Clinical & Translational Immunology|February 23, 2023
Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trialsTobias V Lanz, William H Robinson, Peggy P Ho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systemsPeggy P Ho, Paulo Fontoura, Pedro J Ruiz, et al.
Current Opinion in Immunology|September 3, 2019
Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunityLawrence Steinman, Peggy P Ho, William H Robinson, et al.
Current Trends in Immunology|May 6, 2014
Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitisHarley Y Tse, Jinzhu Li, Xiaoqing Zhao, et al.
Arthritis and Rheumatism|June 26, 2008
Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosusKareem L Graham, Lowen Y Lee, John P Higgins, et al.
Autoimmunity|October 23, 2009
Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W miceKareem L Graham, Lowen Y Lee, John P Higgins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2026
Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosisFok Moon Lum, Neda Sattarnezhad, Peggy P Ho, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cell Research|June 3, 2008
The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in diseasePeggy P Ho, Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitisPeggy P Ho, Lawrence Steinman
Neurology(R) Neuroimmunology & Neuroinflammation|March 9, 2017
Time correlation between mononucleosis and initial symptoms of MSJohn Endriz, Peggy P Ho, Lawrence Steinman
Clinical & Translational Immunology|February 23, 2023
Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trialsTobias V Lanz, William H Robinson, Peggy P Ho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systemsPeggy P Ho, Paulo Fontoura, Pedro J Ruiz, et al.
Current Opinion in Immunology|September 3, 2019
Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunityLawrence Steinman, Peggy P Ho, William H Robinson, et al.
Current Trends in Immunology|May 6, 2014
Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitisHarley Y Tse, Jinzhu Li, Xiaoqing Zhao, et al.
Arthritis and Rheumatism|June 26, 2008
Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosusKareem L Graham, Lowen Y Lee, John P Higgins, et al.
Autoimmunity|October 23, 2009
Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W miceKareem L Graham, Lowen Y Lee, John P Higgins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2026
Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosisFok Moon Lum, Neda Sattarnezhad, Peggy P Ho, et al.
Pageof 5